NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS Group AG | 903,272 | $17,360,887 | 0.01% |
| Centiva Capital, LP | 13,514 | $259,739 | 0.01% |
| Leucadia National | 36,100 | $693,842 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 615,418 | $11,828,334 | 0.01% |
| Invesco Ltd. | 1,048,098 | $20,144,443 | 0.01% |
| FEDERATED HERMES, INC. | 89,810 | $1,726,148 | 0.01% |
| OPPENHEIMER ASSET MANAGEMENT INC. | 17,165 | $329,911 | 0.01% |
| NATIXIS | 34,500 | $663,090 | 0.01% |
| Bridgewater Associates | 42,267 | $812,372 | 0.01% |
| AQR Capital Management | 109,244 | $2,099,670 | 0.00% |
| BLAIR WILLIAM & CO/IL | 53,860 | $1,035,189 | 0.00% |
| VIRGINIA RETIREMENT SYSTEMS ET AL | 23,500 | $451,670 | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 158,642 | $3,049 | 0.00% |
| NOMURA HOLDINGS INC | 46,250 | $888,925 | 0.00% |
| SG Americas Securities, LLC | 14,256 | $274 | 0.00% |
| Verition Fund Management LLC | 12,978 | $249,437 | 0.00% |
| MetLife Investment Management, LLC | 18,940 | $364,027 | 0.00% |
| Ameritas Investment Partners, Inc. | 3,529 | $67,827 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,162 | $60,774 | 0.00% |
| GOLDMAN SACHS GROUP INC | 616,890 | $11,856,633 | 0.00% |
External links
This page lists NEVRO CORP's shareholders in Q3 2023. To view NEVRO CORP's shareholder history, click here.